Cleared Traditional

DZ-Tabone Intervertebral Body Fusion Device (K241073) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241073 · Shenzhen Dazhou Medical Technology Co., Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
231d
Days
Class 2
Risk

K241073 is an FDA 510(k) clearance for the DZ-Tabone Intervertebral Body Fusion Device. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Shenzhen Dazhou Medical Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on December 6, 2024 after a review of 231 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Dazhou Medical Technology Co., Ltd. devices

Submission Details

510(k) Number K241073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 2024
Decision Date December 06, 2024
Days to Decision 231 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
109d slower than avg
Panel avg: 122d · This submission: 231d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Cosmos Biomed Consulting
Ray Chang

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 464
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K241073.
AxCess® Expandable Interbody System
K243739 · Elliquence, LLC · Jan 2025
ProLift Pivot Expandable Spacer System
K243668 · Life Spine, Inc. · Jan 2025
Idys® LIF
K243670 · Clariance · Dec 2024
Scarlet® AL-T
K242589 · Spineart SA · Oct 2024
BluEX Lumbar Expandable Cage System
K242829 · L & K Biomed Co., Ltd. · Oct 2024
KLIMT™ Expandable Lumbar Interbody Fusion (LIF) Cage System
K233947 · Ctl Medical Corporation · Oct 2024